Caxton Associates (New York)’s Gevo GEVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-219,916
Closed -$262K 496
2023
Q3
$262K Sell
219,916
-62,770
-22% -$92.8K 0.04% 323
2023
Q2
$430K Buy
+282,686
New +$365K 0.06% 288

Other funds holding GEVO

Caxton Associates (New York)'s GEVO Position: Q4 2023 in Review

Caxton Associates (New York) sold out of Gevo (GEVO) in Q4 2023, closing a stake of 219,916 shares — an estimated $262K sold.

Caxton Associates (New York) first reported a position in GEVO in Q2 2023 and held it in 2 quarters. The position peaked at $430K in Q2 2023. 124 funds tracked by Wall St. Rank hold GEVO as of Q4 2023.

  • Caxton Associates (New York) reported no remaining Gevo position as of Q4 2023 after selling out during the quarter.
  • Caxton Associates (New York) sold 219,916 Gevo shares in Q4 2023, an estimated $262K.
  • Caxton Associates (New York) first reported a position in Gevo in Q2 2023 and held it in 2 quarters.
  • Caxton Associates (New York)'s Gevo position peaked at $430K in Q2 2023.
  • 124 funds tracked by Wall St. Rank held Gevo as of Q4 2023.

Based on Caxton Associates (New York)'s 13F filing for Q4 2023, filed 14 Feb 2024.